The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study
Open accessAbstract
Importance: Nonalcoholic fatty liver disease (NAFLD) is a common condition that is most often asymptomatic. It is associated with metabolic syndrome, incident diabetes, carotid atherosclerosis, and endothelial dysfunction, conditions that in turn are strongly linked with brain damage and cognitive impairment. However, it is not known whether NAFLD is associated with structural brain measures in humans. Objective: To assess the association between prevalent NAFLD and brain magnetic resonance imaging (MRI) measures. Design, Setting, and Participants: The cross-sectional association between NAFLD and brain MRI measures was assessed from November 6, 2002, to March 16, 2011, in 766 individuals from the Offspring cohort of the Framingham Study. Participants were included if they did not have excessive alcohol intake and were free of stroke and dementia. Data analysis was conducted from December 30, 2015, to June 15, 2016. Exposures: Nonalcoholic fatty liver disease was assessed by multidetector computed tomographic scans of the abdomen. Main Outcomes and Measures: Linear or logistic regression models were used to evaluate the cross-sectional association between NAFLD and brain MRI measures, adjusting for age, sex, alcohol consumption, visceral adipose tissue, body mass index, menopausal status, systolic blood pressure, hypertension, current smoking, high-density lipoprotein and low-density lipoprotein cholesterol levels, lipid treatment, type 2 diabetes, cardiovascular disease, physical activity, insulin resistance, C-reactive protein levels, and plasma homocysteine values. Brain MRI measures included total cerebral brain volume, hippocampal and white matter hyperintensity volumes, and presence or absence of covert brain infarcts. Results: Of the 766 individuals in the study sample (410 women and 356 men; mean [SD] age at the time of brain MRI, 67 [9] years), 137 (17.9%) had NAFLD. Nonalcoholic fatty liver disease was significantly associated with smaller total cerebral brain volume even after adjustment for all the covariates included in the study (β [SE], -0.26 [0.11]; P = .02). Differences in total cerebral brain volume between those with and without NAFLD corresponded to 4.2 years of brain aging in the general sample and to 7.3 years in individuals younger than 60 years of age. No statistically significant associations were observed between NAFLD and hippocampal or white matter hyperintensity volumes or covert brain infarcts. Conclusions and Relevance: Nonalcoholic fatty liver disease is associated with a smaller total cerebral brain volume, independent of visceral adipose tissue and cardiometabolic risk factors, pointing to a possible link between hepatic steatosis and brain aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Liver biopsies from older adults revealed that the degree of liver ageing is related to the severity of nonalcoholic fatty liver disease (NAFLD),220 which increases the brain age by approximately 4.2 years.221”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [221]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Self-citationVernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,116
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882
Self-citationVilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Williams, C. D., Stengel, J. Z., Asike, M., Torres, D. M., Shaw, J. C., Contreras, M., Landt, C. L., & Harrison, S. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,182
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Loomba, R. S., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,732
The framingham offspring study. Design and preliminary data
Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M., & Castelli, W. P. (1975) · Preventive Medicine · doi:10.1016/0091-7435(75)90037-7 · Cited by 926
Pou, K. M., Massaro, J. M., Hoffmann, U., Vasan, R. S., Maurovich‐Horvat, P., Larson, M. G., Keaney, J. F., Meigs, J. B., Lipinska, I., Kathiresan, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.710509 · Cited by 915
Self-citation
Cited by
Sorted by citations
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy
Rose, C. F., Amodio, P., Bajaj, J. S., Dhiman, R. K., Montagnese, S., Taylor-Robinson, S. D., Vilstrup, H., & Jalan, R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.013 · Cited by 509
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
Montagnese, S., Rautou, P., Romero‐Gómez, M., Larsen, F. S., Shawcross, D. L., Thabut, D., Vilstrup, H., & Weißenborn, K. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.001 · Cited by 481
Obesity and aging: Molecular mechanisms and therapeutic approaches
Santos, A. L., & Sinha, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101268 · Cited by 249
Nho, K., Kueider-Paisley, A., Ahmad, S., MahmoudianDehkordi, S., Arnold, M., Risacher, S. L., Louie, G., Blach, C., Baillie, R., Han, X., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.7978 · Cited by 227
Gehrke, N., & Schattenberg, J. M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.020 · Cited by 216
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
Labenz, C., Huber, Y., Michel, M. S., Nagel, M., Galle, P. R., Kostev, K., & Schattenberg, J. M. (2020) · Hepatology Communications · doi:10.1002/hep4.1541 · Cited by 133
Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease
Luo, Y., & Lin, H. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.391 · Cited by 132
Obesity-induced inflammation: connecting the periphery to the brain
Le Thuc, O., & García-Cáceres, C. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01079-8 · Cited by 125
Weinstein, G., Davis‐Plourde, K. L., Himali, J. J., Zelber‐Sagi, S., Beiser, A., & Seshadri, S. S. (2019) · Liver International · doi:10.1111/liv.14161 · Cited by 115
Self-citationKjærgaard, K., Mikkelsen, A. C. D., Wernberg, C. W., Grønkjær, L. L., Eriksen, P. L., Damholdt, M. F., Mookerjee, R. P., Vilstrup, H., Lauridsen, M. M., & Thomsen, K. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040673 · Cited by 116
Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease
Cheng, Y., He, C.-Y., Tian, D.-Y., Chen, S.-H., Ren, J.-R., Sun, H.-L., Xu, M.-Y., Tan, C.-R., Fan, D.-Y., Jian, J.-M., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02559-z · Cited by 110
Cao, L., An, Y., Zhao, Z., Liu, H., Jiang, J., Liu, W., Zhou, Y., Shi, M., Dai, W., Lv, Y., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03315-0 · Cited by 116
Importance of fatigue and its measurement in chronic liver disease
Gerber, L. H., Weinstein, A. A., Mehta, R., & Younossi, Z. M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i28.3669 · Cited by 94
Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study
Shang, Y., Widman, L., & Hagström, H. (2022) · Neurology · doi:10.1212/wnl.0000000000200853 · Cited by 85
Tuttolomondo, A., Petta, S., Casuccio, A., Maida, C. D., Corte, V. D., Daidone, M., Raimondo, D. D., Pecoraro, R., Fonte, R., Cirrincione, A., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0670-7 · Cited by 80
Cól, J. P. D., de Lima, E. P., Pompeu, F. M., Araújo, A. C., Goulart, R. D. Á., Bechara, M. D., Laurindo, L. F., Méndez‐Sánchez, N., & Barbalho, S. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073694 · Cited by 86
Multi-organ imaging demonstrates the heart-brain-liver axis in UK Biobank participants
McCracken, C., Raisi‐Estabragh, Z., Veldsman, M., Raman, B., Dennis, A., Husain, M., Nichols, T. E., Petersen, S. E., & Neubauer, S. (2022) · Nature Communications · doi:10.1038/s41467-022-35321-2 · Cited by 71
GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight
Monti, G., Moreira, D. G., Richner, M., Mutsaers, H. A. M., Ferreira, N., & Jan, A. (2022) · Cells · doi:10.3390/cells11132023 · Cited by 72
Weiss, N., & Thabut, D. (2019) · Liver Transplantation · doi:10.1002/lt.25420 · Cited by 72
Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review
Lombardi, R., Fargion, S. R., & Fracanzani, A. L. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.05.015 · Cited by 66
Sookoian, S. C., & Pirola, C. J. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15163 · Cited by 66
Raber, J., Arzy, S., Bertolus, J. B., Depue, B., Haas, H. E., Hofmann, S. G., Kangas, M., Kensinger, E., Lowry, C. A., Marusak, H. A., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.015 · Cited by 62
Cholesterol metabolism in aging simultaneously altered in liver and nervous system
Nunes, V. S., Ferreira, G. D. S., & Quintão, E. C. R. (2022) · Aging · doi:10.18632/aging.203880 · Cited by 67
Hepatic Encephalopathy: From Metabolic to Neurodegenerative
Ochoa‐Sanchez, R., Tamnanloo, F., & Rose, C. F. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03372-4 · Cited by 56
Cheon, S. Y., & Song, J. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00836-0 · Cited by 58
Gentile, F., Doneddu, P. E., Riva, N., Nobile‐Orazio, E., & Quattrini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207471 · Cited by 58
The liver–brain axis in metabolic dysfunction-associated steatotic liver disease
Mikkelsen, A. C. D., Kjærgaard, K., Schapira, A. H. V., Mookerjee, R. P., & Thomsen, K. L. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00320-0 · Cited by 60
Beck, D., de Lange, A. G., Alnæs, D., Maximov, I. I., Pedersen, M. L., Leinhard, O. D., Linge, J., Simon, R. A., Richard, G., Ulrichsen, K. M., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102949 · Cited by 49
Weinstein, G., O’Donnell, A., Davis‐Plourde, K. L., Zelber‐Sagi, S., Ghosh, S., DeCarli, C. S., Thibault, E. G., Sperling, R. A., Johnson, K. A., Beiser, A., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215409 · Cited by 51
Self-citationJeong, S., Oh, Y. H., Choi, S., Chang, J., Kim, S. M., Son, J. S., Lee, G., Ahn, J. C., Lee, D. H., Koo, B. K., et al. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0332 · Cited by 49
Kim, G., Oh, C. H., Kim, J., Jeong, S. J., Oh, I., Lee, J. S., Park, K., & Shim, J. (2022) · Liver International · doi:10.1111/liv.15244 · Cited by 48
Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
Labenz, C., Kostev, K., Kaps, L., Galle, P. R., & Schattenberg, J. M. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06644-1 · Cited by 47
Lv, H., Zeng, N., Li, M., Sun, J., Wu, N., Xu, M., Chen, Q., Zhao, X., Chen, S., Liu, W., et al. (2024) · Health Data Science · doi:10.34133/hds.0087 · Cited by 46
Cervo, A., Shengir, M., Patel, K., & Sebastiani, G. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00531-0 · Cited by 46
Boccara, E., Golan, S., & Beeri, M. S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1160426 · Cited by 47
Shang, Y., Nasr, P., Ekstedt, M., Widman, L., Stal, P. I., Hultcrantz, R. W., Kechagias, S., & Hagström, H. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100218 · Cited by 44
Yang, Y., Li, X., Liu, Z., Ruan, X., Wang, H. H., Zhang, Q., Cao, L., Song, L., Chen, Y., & Sun, Y. (2022) · Nutrients · doi:10.3390/nu14224910 · Cited by 45
Elevated C-reactive protein mediates the liver-brain axis: a preliminary study
Jiang, R., Wu, J., Rosenblatt, M., Dai, W., Rodriguez, R. X., Sui, J., Qi, S., Liang, Q., Xu, B., Meng, Q., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104679 · Cited by 46
From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function
Medina‐Julio, D., Ramírez-Mejía, M. M., Córdova‐Gallardo, J., Peniche-Luna, E., Cantú-Brito, C. G., & Méndez‐Sánchez, N. (2024) · Medical Science Monitor · doi:10.12659/msm.943417 · Cited by 45
Meroni, M., Longo, M., Paolini, E., & Dongiovanni, P. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.02.007 · Cited by 52
Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?
Goodus, M. T., & McTigue, D. M. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113160 · Cited by 47
Liver integrity and the risk of Alzheimer's disease and related dementias
Lü, Y., Pike, J. R., Hoogeveen, R. C., Walker, K. A., Raffield, L. M., Selvin, E., Avery, C. L., Engel, S. M., Mielke, M. M., Garcia, T., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13601 · Cited by 43
Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study
Gerber, Y., VanWagner, L. B., Yaffe, K. S., Terry, J. G., Rana, J. S., Reis, J. P., & Sidney, S. S. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01681-0 · Cited by 43
Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease
Nawrot, M., Peschard, S., Lestavel, S., & Staels, B. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154844 · Cited by 49
Palmer, N. D., Kahali, B., Kuppa, A., Chen, Y., Du, X., Feitosa, M. F., Bielak, L. F., O’Connell, J. R., Musani, S. K., Guo, X., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab096 · Cited by 40
Self-citationSayıner, M., Arshad, T., Golabi, P., Paik, J. M., Farhat, F., & Younossi, Z. M. (2020) · Hepatology International · doi:10.1007/s12072-020-10038-w · Cited by 40
Population-based body–brain mapping links brain morphology with anthropometrics and body composition
Gurholt, T. P., Kaufmann, T., Frei, O., Alnæs, D., Haukvik, U. K., van der Meer, D., Moberget, T., O’Connell, K. S., Leinhard, O. D., Linge, J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01414-7 · Cited by 38
Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD
Petta, S., Armandi, A., & Bugianesi, E. (2024) · Liver International · doi:10.1111/liv.16133 · Cited by 38
Avenues within the gut-liver-brain axis linking chronic liver disease and symptoms
Nguyen, H. H., & Swain, M. G. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1171253 · Cited by 40
Kjærgaard, K., Mikkelsen, A. C. D., Landau, A. M., Eriksen, P. L., Hamilton-Dutoit, S. J., Magnusson, N. E., Thomsen, M. B., Chen, F., Vilstrup, H., Mookerjee, R. P., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100992 · Cited by 41
Liu, Q., Liu, C., Hu, F., Deng, X., & Zhang, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.738835 · Cited by 38
Weinstein, G., O’Donnell, A., Frenzel, S., Xiao, T., Yaqub, A., Yilmaz, P., de Knegt, R. J., Maestre, G. E., van Lent, D. M., Long, M. T., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.16048 · Cited by 36
Self-citationSingh, A., Kaur, N., Kaushal, S., Tyagi, R., Mathur, D., Sivapuram, M. S., Metri, K., Bammidi, S., Podder, V., Modgil, S., et al. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.007 · Cited by 36
Ahmad, N. A., Raizman, M., Weizmann, N., Wasek, B. L., Arning, E., Bottiglieri, T., Tirosh, O., & Troen, A. M. (2019) · The FASEB Journal · doi:10.1096/fj.201802683r · Cited by 36
The Presence and Severity of NAFLD are Associated With Cognitive Impairment and Hippocampal Damage
Miao, Y., Zhang, B., Sun, X., Ma, X., Fang, D., Zhang, W., Wu, T., Xu, X. M., Yu, C., Hou, Y., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad352 · Cited by 37
MAFLD progression contributes to altered thalamus metabolism and brain structure
Nucera, S., Ruga, S., Cardamone, A., Coppoletta, A. R., Guarnieri, L., Zito, M. C., Bosco, F., Macrì, R., Scarano, F., Scicchitano, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05228-5 · Cited by 30
Wang, M., Zhou, B., Zhang, Y., Ren, X.-F., Li, L., Li, B., & Ai, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.812030 · Cited by 33
Wang, Y., Li, Y., Liu, K., Han, X., Dong, Y., Wang, X., Wang, M., Cong, L., Zhang, Q., Tang, S. H., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15416 · Cited by 30
Chiara, F. D., Ferret-Miñana, A., & Ramón‐Azcón, J. (2021) · Biomedicines · doi:10.3390/biomedicines9030248 · Cited by 30
Giuffrè, M., Merli, N., Pugliatti, M., & Moretti, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063337 · Cited by 29
Bao, X., Kang, L., Yin, S., Engström, G., Wang, L., Xu, W., Xu, B., Zhang, X., & Zhang, X. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01498-5 · Cited by 32
Balcar, L., Krawanja, J., Scheiner, B., Paternostro, R., Simbrunner, B., Semmler, G., Jachs, M., Hartl, L., Stättermayer, A. F., Schwabl, P., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100682 · Cited by 26
Melazzini, L., Vitali, P., Olivieri, E., Bolchini, M., Zanardo, M., Savoldi, F., Leo, G. D., Griffanti, L., Baselli, G., Sardanelli, F., et al. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27479 · Cited by 23
Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?
Hadjihambi, A. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114387 · Cited by 25
Peng, Z., Duggan, M. R., Dark, H. E., Daya, G. N., An, Y., Davatzikos, C. A., Erus, G., Lewis, A., Moghekar, A., & Walker, K. A. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.08.004 · Cited by 24
Neurodegeneration in juvenile Iberian pigs with diet-induced nonalcoholic fatty liver disease
Zeltser, N., Meyer, I., Hernandez, G. V., Trahan, M. J., Fanter, R. K., Abo-Ismail, M. K., Glanz, H., Strand, C. R., Burrin, D. G., Frano, M. R. L., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00120.2020 · Cited by 25
Gil‐Gómez, A., Brescia, P., Rescigno, M., & Romero‐Gómez, M. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1723752 · Cited by 24
Subclinical liver traits are associated with structural and hemodynamic brain imaging markers
Yilmaz, P., Alferink, L. J. M., Cremers, L. G. M., Murad, S. D., Niessen, W. J., Ikram, M. A., & Vernooij, M. W. (2023) · Liver International · doi:10.1111/liv.15549 · Cited by 25
Clayton‐Chubb, D., Kemp, W. W., Majeed, A., Woods, R. L., Ryan, J. L., Murray, A. M., Chong, T. T. ‐., Lubel, J. S., Tran, C., Hodge, A. D., et al. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae011 · Cited by 22
Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study
Cushman, M., CALLAS, P. W., Alexander, K., Wadley, V. G., Zakai, N. A., Lidofsky, S. D., Unverzagt, F. W., & Judd, S. E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282633 · Cited by 21
Golan, S., Boccara, E., Ravona‐Springer, R., Inbar, Y., Zelicha, H., Livny, A., Bendlin, B. B., Lesman‐Segev, O. H., Yore, I., Heymann, A. D., et al. (2024) · Obesity · doi:10.1002/oby.24004 · Cited by 21
Acharya, C., & Bajaj, J. S. (2021) · Liver Transplantation · doi:10.1002/lt.26099 · Cited by 23
Beller, E., Lorbeer, R., Keeser, D., Schoeppe, F., Sellner, S., Hetterich, H., Bamberg, F., Schlett, C. L., Peters, A., Ertl-Wagner, B. B., et al. (2019) · European Radiology · doi:10.1007/s00330-019-06276-8 · Cited by 21
Kaplan, H. S., Hooper, P. L., Gatz, M., Mack, W. J., Law, E. M., Chui, H. C., Sutherland, M. L., Sutherland, J. D., Rowan, C. J., Wann, L. S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205448120 · Cited by 20
Chen, L., Zhang, L., Liu, S., Hua, H., Zhang, L., Liu, B., & Wang, R. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01979-23 · Cited by 19
Nonalcoholic Fatty Liver Disease.
Ding, L.-L., Oligschlaeger, Y., Shiri-Sverdlov, R., & Houben, T. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_352 · Cited by 4
Wang, J., Yang, R., Miao, Y., Zhang, X., Paillard‐Borg, S., Fang, Z., & Xu, W. (2025) · Liver International · doi:10.1111/liv.70109 · Cited by 18
Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration
Kelty, T. J., Dashek, R. J., Arnold, W. D., & Rector, R. S. (2023) · Seminars in Liver Disease · doi:10.1055/s-0043-1762585 · Cited by 19
Lü, Y., Pike, J. R., Hoogeveen, R. C., Walker, K. A., Raffield, L. M., Selvin, E., Avery, C. L., Engel, S. M., Mielke, M. M., Garcia, T., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209203 · Cited by 17
Arold, D., Bornstein, S. R., Perakakis, N., Ehrlich, S., & Bernardoni, F. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155983 · Cited by 18
Basu, E., Mehta, M., Zhang, C., Zhao, C., Rosenblatt, R. E., Tapper, E. B., & Parikh, N. S. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120117 · Cited by 17
Mikkelsen, A. C. D., Kjærgaard, K., Mookerjee, R. P., Vilstrup, H., Wegener, G., Bay-Richter, C., & Thomsen, K. L. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03551-x · Cited by 18
Xu, J.-L., Gu, J.-P., Wang, L., Zhu, Q., You, N., Li, J., Li, J., & Shi, J. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2201008 · Cited by 16
Cognitive Function in Liver Transplantation
Albhaisi, S. A. M., & Bajaj, J. S. (2020) · Current Transplantation Reports · doi:10.1007/s40472-020-00274-2 · Cited by 16
Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease
Parikh, N. S., Wahbeh, F., Tapia, C., Ianelli, M., Liao, V., Jaywant, A., Kamel, H., Kumar, S. R., & Iadecola, C. (2024) · BMJ Neurology Open · doi:10.1136/bmjno-2023-000543 · Cited by 15
Fatty liver and cerebrovascular disease: plausible association and possible mechanisms
Khanna, S., Parikh, N. S., & VanWagner, L. B. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000799 · Cited by 14
Deng, M., Li, Z., Sun, L., Wang, H., Tang, J., Liu, Y., Chen, X., Xu, H., & Dai, Z. (2025) · Radiology · doi:10.1148/radiol.250026 · Cited by 13
Chen, J., Wang, L., Zhou, Y., Zhao, S., Chen, Q., & Zheng, K. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100478 · Cited by 13
Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
Morega, S., Cătălin, B., Simionescu, C. E., Sapalidis, K. G., & Rogoveanu, I. (2021) · Brain Sciences · doi:10.3390/brainsci11121622 · Cited by 13
Kaya, E., & Yilmaz, Y. N. (2024) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2024.23629 · Cited by 16
Jeong, S., Kwon, H., Park, S., Yu, S. J., Jeong, H., Nam, K., Kwon, H., & Park, J. (2019) · European Journal of Neurology · doi:10.1111/ene.14029 · Cited by 13
Zhang, H., Farooqui, H. F. M., Zhu, W., Niu, T., Zhang, Z., & Zhang, H. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01211-w · Cited by 14
Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes
Mantovani, A., Targher, G., & Zoppini, G. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.04.010 · Cited by 12
Alzheimer's disease, a metabolic disorder: Clinical advances and basic model studies (Review)
Zhou, S., Tu, L., Chen, W., Yan, G., Guo, H., Wang, X., Hu, Q., Liu, H., & Li, F. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12351 · Cited by 12
Xia, W., Yang, N., & Li, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.922913 · Cited by 12
Shu, K., Ye, X., Song, J., Huang, X., Cui, S., Zhou, Y., Liu, X., Han, L., Yan, Z., & Liu, K. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05071-6 · Cited by 11
Multimodal Learning-based Prediction for Nonalcoholic Fatty Liver Disease
Chen, Y., Chen, X., Han, Y., Li, H., Zhao, D., Li, J., Wang, X., & Zhou, Y. (2025) · Machine Intelligence Research · doi:10.1007/s11633-024-1506-4 · Cited by 12
Therapeutic effects of CD133 + Exosomes on liver function after stroke in type 2 diabetic mice
Venkat, P., Gao, H., Findeis, E. L., Chen, Z., Zacharek, A., Landschoot‐Ward, J., Powell, B., Lü, M., Liu, Z., Zhang, Z., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1061485 · Cited by 10
Metadata
- Authors
- Weinstein, G., Zelber-Sagi, S., Preis, S. R., Beiser, A. S., DeCarli, C., Speliotes, E. K., Satizabal, C. L., Vasan, R. S., & Seshadri, S.
- Affiliations
- University of Haifa (IL)
- School of Public Health, University of Haifa, Haifa, Israel
- Boston University (US)
- University of California, Davis (US)
- Broad Institute (US)
- The Framingham Study, Framingham, Massachusetts
- Corresponding author
- Weinstein, Galit
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2018-01-01
- Volume
- 75
- Issue
- 1
- Pages
- 97
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC5833484
- OpenAlex
- W2770554136
- Cited by
- 186
- References
- 59
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 35 · 2023: 30 · 2022: 24 · 2021: 19 · 2020: 17 · 2019: 12 · 2018: 2
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30AG010129)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107904, R01DK106621)
- National Institute of Neurological Disorders and Stroke (R01NS017950)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- non-alcoholic fatty liver disease, brain volume, hippocampal hyperintensity, white matter hyperintensities, brain aging, middle-aged adults, metabolic syndrome, cognitive impairment, Framingham Offspring cohort, brain MRI, cardiovascular risk factors, insulin resistance, homocysteine
- MeSH terms
- Abdomen, Aged, Alcohol Drinking, Brain, C-Reactive Protein, Carotid Artery Diseases, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Magnetic Resonance Imaging, Male, Middle Aged, Risk Factors, Cohort Studies, Tomography Scanners, X-Ray Computed, Prevalence, Logistic Models, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
